{
    "nct_id": "NCT06323044",
    "official_title": "MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication Adherence",
    "inclusion_criteria": "* Parent of a child who is diagnosed and receiving first line therapy for acute lymphoblastic leukemia (ALL) at a study site.\n* Parent's child patient is age 365 days to < 19 years at time of study entry.\n* Parent's child patient's therapy must include 6-mercaptopurine (6-MP) administered orally or by nasogastric (NG) tube.\n* Parent has verbal English, French, or Spanish fluency.\n* Parent has a smartphone or access to a computer with an Internet connection.\n* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure.\nHealthy volunteers allowed",
    "exclusion_criteria": "* Parent is unwilling or unable to follow protocol requirements.",
    "miscellaneous_criteria": ""
}